P3 Health Partners (PIII) Projected to Post Earnings on Thursday

P3 Health Partners (NASDAQ:PIII) is anticipated to issue its Q4 2025 results before the market opens on Thursday, March 26th. Analysts expect the company to announce earnings of ($8.0633) per share and revenue of $357.65 million for the quarter. Investors can find conference call details on the company’s upcoming Q4 2025 earning report page for the latest details on the call scheduled for Thursday, March 26, 2026 at 4:30 PM ET.

P3 Health Partners Price Performance

P3 Health Partners stock opened at $2.69 on Thursday. P3 Health Partners has a 52-week low of $1.52 and a 52-week high of $11.30. The company has a quick ratio of 0.32, a current ratio of 0.32 and a debt-to-equity ratio of 2.29. The firm’s fifty day moving average is $2.50 and its 200 day moving average is $5.45. The company has a market cap of $19.39 million, a price-to-earnings ratio of -0.07 and a beta of 0.86.

Analyst Ratings Changes

A number of research firms have recently weighed in on PIII. Weiss Ratings restated a “sell (e+)” rating on shares of P3 Health Partners in a report on Thursday, January 22nd. BTIG Research reaffirmed a “neutral” rating on shares of P3 Health Partners in a report on Friday, December 12th. One research analyst has rated the stock with a Buy rating, one has issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, P3 Health Partners presently has a consensus rating of “Hold” and a consensus target price of $12.50.

P3 Health Partners Company Profile

P3 Health Partners is a healthcare technology and services company that delivers data-driven solutions to support health plans in improving quality measures, risk adjustment accuracy and operational efficiency. The company’s platform integrates advanced analytics, reporting capabilities and workflow automation to help clients optimize performance across value-based care programs and regulatory requirements.

The company’s core offerings include quality measurement and reporting for HEDIS, STAR and other performance frameworks, risk adjustment coding and audit services, and population health analytics.